Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianliebeixi capsule with or without tamsulosin for chronic prostatitis
ChiCTR1900025811Phase 4Not yet recruiting
- Sponsor
- Changhai Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of qianliebeixi capsule and tamsulosin in chronic prostatitis (CP) (3 arms), sponsored by Changhai Hospital. Primary endpoint: NIH Chronic Prostatitis Symptom Index. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
qianliebeixi capsuletamsulosin
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR1900025811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025811.